New Key Statistics Module, Z-Score and F-Score
NAS:CARA Key Ratios
Market Cap $ M | 39.12 |
Enterprise Value $ M | -55.55 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.68 |
Price/Sales | 1.85 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 20.00 |
EPS (TTM) $ | -2.19 |
Beneish M-Score | -3.69 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.47 |
EV-to-EBITDA | 0.47 |
PEG | -- |
Shares Outstanding M | 54.67 |
Net Margin (%) | -565.21 |
Operating Margin % | -579.43 |
Pre-tax Margin (%) | -565.21 |
Quick Ratio | 4.43 |
Current Ratio | 4.54 |
ROA % (ttm) | -83.33 |
ROE % (ttm) | -108.32 |
ROIC % (ttm) | -587.15 |
Dividend Yield % | -- |
Altman Z-Score | -9.35 |
CARA Number of Guru Trades
CARA Volume of Guru Trades
Gurus Latest Trades with NAS:CARA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CARA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cara Therapeutics Inc Insider Transactions
No Available Data
News about NAS:CARA
Total 0- 1